Texas A&M study links canine and human aging biomarkers
Bottom line
Dogs and people may share more of aging biology than many clinicians assumed. A new Dog Aging Project study, led by researchers at Texas A&M and collaborators, found that blood metabolites linked to earlier or later death in dogs tracked closely with the same mortality-associated metabolites reported in human studies. The paper, published in The Journals of Gerontology: Series A, analyzed plasma metabolomics from 937 dogs in the project’s Precision Cohort and found 23 metabolites significantly associated with all-cause mortality after adjustment for age, weight, sex, creatinine, and genetic relatedness. (academic.oup.com)
Why it matters: For veterinary professionals, the finding strengthens the case for companion dogs as a practical translational model for aging research, especially because they share human-built environments, common chronic diseases, and access to sophisticated medical care, but age on a much shorter timeline. The researchers say that could help identify clinically relevant biomarkers and intervention targets faster than human-only studies, while also reinforcing familiar preventive priorities for pet parents: healthy body weight, nutrition, mobility, and cognitive health. (academic.oup.com)
What to watch: As the Dog Aging Project continues annual follow-up and multi-omic sampling, expect more work tying metabolomic signals to specific age-related diseases, healthspan measures, and potential interventions. (pubmed.ncbi.nlm.nih.gov)
Key facts
- Study type
- Plasma metabolomics mortality analysis
- Study cohort
- 937 dogs from the Dog Aging Project Precision Cohort
- Metabolites assessed
- 133
- Mortality-associated metabolites
- 23 met a false-discovery threshold of less than 5%
- Deaths observed
- 104
- Follow-up
- Average 2.6 years, maximum 3.9 years
- Human comparison
- Nine published human mortality studies
- Main finding
- 64% of shared metabolites showed the same direction of mortality risk in dogs and humans
A new Texas A&M-led Dog Aging Project paper adds weight to an idea that’s been building across comparative medicine: dogs may be one of the best real-world models for understanding how aging unfolds in people. In the study, published in The Journals of Gerontology: Series A, researchers reported that blood-based metabolite patterns associated with mortality in dogs were strongly aligned with those seen in multiple human cohorts. (academic.oup.com)
The work comes out of the Dog Aging Project, a long-running, open-data effort following more than 50,000 U.S. companion dogs over time. Within that broader program, the Precision Cohort was built as a deeply phenotyped, multi-omic subgroup designed to support longitudinal aging research through annual sampling, owner survey data, and collaboration with primary care veterinarians across the country. A 2025 methods paper described the cohort as 1,000 dog-owner pairs, with biospecimens ultimately collected from 976 dogs, creating infrastructure for metabolomic, microbiome, epigenomic, and clinical analyses. (pubmed.ncbi.nlm.nih.gov)
For this mortality analysis, investigators used plasma samples from 937 dogs and modeled time to all-cause death using repeated annual data. They assessed 133 metabolites and found that about 17% were associated with mortality, with 23 meeting a false-discovery threshold of less than 5%. The study included 104 deaths over an average follow-up of 2.6 years, with a maximum of 3.9 years. Researchers then compared the canine findings with nine published human mortality studies, including five with enough overlapping metabolites for direct concordance testing. (academic.oup.com)
The overlap was notable. Across the five directly comparable human studies, 64% of shared metabolites showed the same direction of mortality risk in dogs and humans, a result the authors reported as highly significant. Correlations between dog and human hazard ratios ranged from 0.46 to 0.74, and when data from all nine human studies were aggregated, the overall correlation with the canine data was 0.52. Among the shared signals were higher risk with more abundant pseudouridine, N2,N2-dimethylguanosine, and homocitrulline, and lower risk with more abundant deoxycarnitine and homoarginine. The authors noted that several of these metabolites are tied to renal physiology in humans, suggesting a possible shared kidney-related axis in aging biology across species. (academic.oup.com)
Texas A&M’s accompanying release framed the study as evidence that the same biological signals that help predict lifespan in people also appear in dogs. Kate Creevy, DVM, MS, DACVIM, chief veterinary officer for the Dog Aging Project and a professor at Texas A&M, said the findings show that molecules associated with earlier or later death are “very similar” in dogs and people, and argued that pet dogs have particular value as a model because their lifestyles often mirror those of their pet parents more closely than other companion animals do. The Dog Aging Project also highlighted that the work was only possible because of its diverse, community-based cohort. (vetmed.tamu.edu)
Why it matters: For veterinary professionals, this is less about an immediate new test to order and more about validation of the companion dog as a clinically relevant aging model. That matters because the field is moving toward biomarker-guided approaches to frailty, cognition, chronic disease risk, and longevity. The Dog Aging Project has already been building the underlying infrastructure for that future through open-data metabolomics, epigenomics, and longitudinal clinical follow-up, and related project publications have started identifying other blood-based aging signals as well. In practical terms, the study also supports a message many clinicians already give pet parents: the pillars of healthy aging in people and dogs likely overlap more than they differ. (pubmed.ncbi.nlm.nih.gov)
The broader industry context also helps explain why this research is getting attention. Veterinary and biotech groups have been investing heavily in canine longevity science, from longitudinal datasets to diagnostics, wearables, and drug development, in part because dogs offer a compressed timeline for studying healthspan. This new paper doesn’t validate any one commercial intervention, but it does strengthen the scientific rationale behind using companion dogs to test aging hypotheses that could matter on both sides of the human-animal health divide. That’s likely to resonate with clinicians watching the space evolve from observational science toward translational applications. (vetmed.tamu.edu)
What to watch: The next phase is whether these mortality-linked metabolite patterns can be connected to specific diseases, clinical decision-making tools, or interventional studies as the cohort matures and additional years of follow-up accumulate. (academic.oup.com)